Key stats
About L&G Healthcare Technology & Innovation UCITS ETF Accum Shs USD
Home page
Inception date
Jun 17, 2019
Structure
Irish VCIC
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
LGIM Managers (Europe) Ltd.
ISIN
IE00BK5BC677
The L&G Healthcare Breakthrough UCITS ETF (the ETF) aims to track the performance of the ROBO Global Healthcare Technology and Innovation Index TR (the Index).
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.94%
Health Technology83.91%
Commercial Services4.90%
Technology Services4.12%
Health Services3.91%
Electronic Technology1.56%
Retail Trade1.53%
Bonds, Cash & Other0.06%
Cash0.06%
Stock breakdown by region
North America79.63%
Europe17.71%
Asia2.66%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
DOCT invests in stocks. The fund's major sectors are Health Technology, with 83.91% stocks, and Commercial Services, with 4.90% of the basket. The assets are mostly located in the North America region.
DOCT top holdings are Adaptive Biotechnologies Corp. and Alnylam Pharmaceuticals, Inc, occupying 2.01% and 2.00% of the portfolio correspondingly.
DOCT assets under management is 64.90 M EUR. It's risen 12.84% over the last month.
DOCT fund flows account for 3.61 M EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, DOCT doesn't pay dividends to its holders.
DOCT shares are issued by Legal & General Group Plc under the brand L&G. The ETF was launched on Jun 17, 2019, and its management style is Passive.
DOCT expense ratio is 0.49% meaning you'd have to pay 0.49% of your investment to help manage the fund.
DOCT follows the ROBO Global Healthcare Technology and Innovation ETF. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
DOCT invests in stocks.
DOCT price has risen by 0.95% over the last month, and its yearly performance shows a −4.47% decrease. See more dynamics on DOCT price chart.
NAV returns, another gauge of an ETF dynamics, showed a −3.82% decrease in three-month performance and has decreased by −4.32% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −3.82% decrease in three-month performance and has decreased by −4.32% in a year.
DOCT trades at a premium (0.47%) meaning the ETF is trading at a higher price than the calculated NAV.